TTrialPathMatch Me to Trials
← Back to trials
RecruitingInfertility, FemaleObesity

Convergent Mechanisms Underlying Reprometabolic Syndrome in Women

Eligible age

18–38 yrs

Accepts

Women

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Dr. Nanette Santoro proposes to test the specific question that obesity results in abnormal estradiol response at the level of the pituitary and hypothalamus. This will be shown in diminished pituitary sensitivity to gonadorelin releasing hormone with a reduced estradiol induced luteinizing hormone surge in obese women.

Sponsor: University of Colorado, Denver

You may qualify if…

  • Age 18-38
  • Regular menstrual cycles every 25-35 days
  • No use of reproductive hormones within the past 3 months
  • No use of medications interacting with reproductive hormones
  • Agreement to use reliable barrier contraception or to abstain from intercourse for the duration of the study
  • Normal thyroid stimulating hormone, prolactin and lipid profiles
  • No more than 4 hours of moderate to vigorous intensity exercise per week
  • No history of chronic disease impacting reproductive hormones

You may not qualify if…

  • Has diabetes
  • Is a smoker
  • History of venous thromboembolism or known thrombophilia

Where it's recruiting

Colorado

Aurora

Source: ClinicalTrials.gov · NCT06686537 · last updated 2026-07-21

Convergent Mechanisms Underlying Reprometabolic Syndrome in Women · TrialPath